• Friday, October 21, 2022

  • CUI

  • International Office

Call for Papers for International Symposium on ‘Innovation of Natural Product Resources of Traditional Chinese Medicine in the Asia-Pacific Region’ (16-18 December 2022), being Organized by the Tianjin Institute of Industrial Biotechnology (TIB), China 

Respected Colleagues,

Greetings from the Commission on Science and Technology for Sustainable Development in the South (COMSATS).

It may kindly be noted that the Tianjin Institute of Industrial Biotechnology (TIB), China, an esteemed Centre of Excellence of COMSATS, is holding the International Symposium on ‘Innovation of Natural Product Resources of Traditional Chinese Medicine in the Asia-Pacific Region’ on 16-18 December 2022 in Tianjin, China. The symposium is focused at the development and application of Traditional Chinese Medicine (TCM) resources in the Asia-Pacific region under the epidemic situation, during which eminent experts and scholars will introduce the latest research progress and new trends in the related fields.

 

In this regard, the relevant experts/scientists of your esteemed Centre of Excellence are invited to submit Abstracts related to the following topics: synthetic biotechnology and innovation of natural product resources; synthetic biotechnology and synthesis of active substances of natural products; physiological and pharmacological activities of natural products of traditional Chinese medicine; and application of natural products of traditional Chinese medicine. The academic committee will select the authors of outstanding abstracts for their online participation in the symposium as speakers. The detailed Call for Papers is enclosed herewith for your kind information and onward dissemination. Further details are given on the following web-link: http://english.tib.cas.cn/ns/ue/202210/t20221014_321603.html

The Abstracts (as per the mentioned template) may be submitted to wuxin@tib.cas.cn, with a copy to fengyy@tib.cas.cn and the undersigned (farhan@comsats.org) by 10th November 2022.

Please accept the assurances of our highest consideration.